Cite

MLA Citation

    Nir Peled et al.. “GLASS: Global Lorlatinib for ALK(+) and ROS1(+) retrospective Study: real world data of 123 NSCLC patients.” Lung cancer, vol. 148, 2020, pp. 48–54. http://access.bl.uk/ark:/81055/vdc_100110428549.0x000042
  
Back to record